Self-cycleTM IVF
-
-
-
Infertility Counselling
-
Female Infertility Treatment
-
Andrology Treatment
-
Fertility Enhancing Surgeries - Female
-
Fertility Enhancing Surgeries - Male
-
Endoscopy Treatment
-
IUI Treatment
-
IVF Treatment
-
ICSI Treatment
-
Advance IVF Solutions
-
Embryology
-
Vitrification Egg, Embryo, Sperm Freezing
-
Preimplantation Genetic Testing (PGT)
-
Donation Program Embryo / Egg / Sperm
-
Self-cycleTM IVF
-
-
-
-
-
IVF with PGT-A in Mumbai: Who May Benefit, Cost Considerations & Treatment Insights
For some couples undergoing IVF treatment, achieving fertilisation is only one step in the journey. The next stage involves selecting embryos with the highest potential for successful implantation and pregnancy. IVF with PGT-A in Mumbai offers an advanced approach to embryo assessment by identifying chromosomal abnormalities before embryo transfer. Specifically, PGT-A (Preimplantation Genetic Testing for Aneuploidy) is used to evaluate the chromosomal makeup of embryos created through IVF. While PGT-A may not be recommended for every patient, it can be beneficial in certain clinical situations. Understanding how the test is used, who may benefit from it, and the factors that influence treatment costs can help couples make informed decisions about their fertility care.
What PGT-A Is and What It Actually Tests For
PGT-A is a form of preimplantation genetic testing performed on embryos created during IVF treatment. It is used to assess whether an embryo has the correct number of chromosomes before transfer. Chromosomes contain the genetic material that guides growth and development. Embryos with an abnormal number of chromosomes may have a lower chance of implantation and may be associated with an increased risk of miscarriage. By identifying chromosomally normal embryos, PGT-A can help support informed embryo transfer decisions during IVF with PGT-A in Mumbai.
The Science Behind Aneuploidy Screening
The term "aneuploidy" refers to the presence of an abnormal number of chromosomes in an embryo. PGT-A helps identify euploid embryos, which have the expected number of chromosomes. As part of chromosomal screening in IVF, this assessment provides valuable information that can help fertility specialists determine which embryos may be suitable for transfer.
How PGT-A Differs From PGT-M and PGT-SR
PGT-A evaluates the number of chromosomes in an embryo, whereas PGT-M is used for couples who are at an increased risk of passing a known genetic condition to their child. PGT-SR, on the other hand, is recommended when one partner carries a structural chromosomal rearrangement that may affect embryo development. While these tests are all forms of preimplantation genetic testing, each serves a distinct purpose based on specific medical and reproductive needs.
Who May Benefit From Adding PGT-A to IVF in Mumbai
Genetic testing is not routinely recommended for every IVF cycle. However, in certain clinical situations, fertility doctors may advise incorporating preimplantation genetic testing in Mumbai as part of the treatment plan.
Women Over 35 With Declining Egg Quality
As women age, their eggs become more likely to develop chromosomal abnormalities. For women aged 35 and above, PGT-A can help identify embryos with the expected number of chromosomes, providing additional information that may support embryo selection during IVF treatment.
Couples With Recurrent Implantation Failure
Multiple IVF failures can be emotionally challenging, particularly when the underlying cause remains unclear. In some cases, embryos may have chromosomal abnormalities that can affect successful implantation. In such situations, PGT-A may provide additional information about embryo chromosomal status, helping fertility specialists make more informed treatment decisions.
Recurrent Pregnancy Loss History
Couples with a history of recurrent pregnancy loss may be advised to consider PGT-A as part of their IVF treatment plan. While miscarriages can occur for a variety of reasons, chromosomal abnormalities in embryos are a recognised cause in some cases. By identifying embryos with the expected number of chromosomes before transfer, PGT-A may provide additional information that can support treatment planning for patients undergoing recurrent miscarriage IVF in Mumbai.
Severe Male Factor Infertility Cases
In cases of severe malefactor infertility, fertility specialists may recommend additional genetic testing as part of the evaluation process. This depends on several factors, including sperm quality, medical history, and the outcome of any previous fertility treatments.
Those Wanting to Reduce Multiple Pregnancy Risk
When a chromosomally normal embryo is identified, fertility specialists may recommend transferring a single embryo. This approach can help reduce the likelihood of multiple pregnancies while maintaining favourable treatment outcomes.
Understanding PGT-A Cost in Mumbai
One of the most common questions couples have when considering IVF with PGT-A in Mumbai relates to the cost of treatment. Since PGT-A is performed in addition to the IVF process, it involves specialised laboratory procedures and genetic testing, which contribute to the overall expense. When evaluating PGT-A cost in Mumbai, it is important to understand the different components involved and the factors that can influence the final treatment cost.
In general, the cost of preimplantation genetic testing may start from around ₹18,000–₹20,000 and can vary depending on the fertility centre, the type of testing performed, laboratory requirements, and the overall treatment plan.
Base IVF Cycle vs. PGT-A Add-On Pricing
A standard IVF cycle typically includes:
- Fertility monitoring
- Egg retrieval
- Fertilisation
- Embryo culture
- Embryo transfer
PGT-A is an additional service performed during the IVF process. It involves testing embryos for chromosomal abnormalities before transfer, which adds specialised laboratory procedures and genetic analysis to the treatment cycle.
Biopsy and Genetic Analysis Fees
PGT-A involves an embryo biopsy followed by detailed genetic analysis in a specialised laboratory. These procedures require advanced technology, stringent laboratory protocols, and highly trained professionals, all of which contribute to the overall cost of testing.
Number of Embryos Tested and Cost Implications
The number of embryos available for testing can also influence the overall treatment cost. Based on the fertility specialist's assessment and the couple's fertility profile, one or more embryos may be recommended for genetic testing. As the number of embryos undergoing analysis increases, laboratory and genetic testing costs may also rise. Pricing structures may vary between fertility centres depending on the services included.
Additional Cost Considerations
In addition to the testing procedure itself, factors such as embryo freezing, storage requirements, and other complementary fertility services may affect the overall cost of treatment. Couples should discuss all potential expenses with their fertility team to gain a clear understanding of the complete treatment plan and associated costs.
The PGT-A Process: What Patients Experience
Understanding the stages involved in IVF with PGT-A in Mumbai can help couples feel more informed and prepared for the treatment journey.
IVF Stimulation and Retrieval (Same as Standard IVF)
The process begins with a standard IVF cycle. Fertility medications are used to stimulate the ovaries to produce multiple eggs, which are then collected through an egg retrieval procedure.
Embryo Culture to Blastocyst Stage
Following fertilisation, the resulting embryos are cultured in the laboratory and monitored as they develop. The goal is for suitable embryos to reach the blastocyst stage, which is typically when preimplantation genetic testing is performed.
Trophectoderm Biopsy Procedure
Once an embryo reaches the blastocyst stage, a trophectoderm biopsy may be performed. During this procedure, a small number of cells are carefully removed from the embryo's outer layer for genetic analysis. These cells are then analysed to assess the embryo's chromosomal status, while the embryo remains available for future treatment decisions.
Genetic Testing Turnaround and Results Interpretation
After the biopsy, the collected cells undergo genetic analysis in a specialised laboratory. Once the results are available, the fertility specialist reviews the findings with the couple and discusses the most appropriate next steps based on the chromosomal status of the embryos.
Frozen Embryo Transfer Timing
Depending on the treatment plan and the time required for genetic analysis, some embryos may be cryopreserved following biopsy. Based on the test results, the fertility specialist may recommend a future embryo transfer cycle if clinically appropriate. The timing of embryo transfer is determined by the couple's fertility health, treatment goals, and clinical recommendations.
Success Rates and Clinical Considerations
Understanding PGT-A success rates in Mumbai is an important consideration for many couples exploring this treatment option. While PGT-A can provide information about the chromosomal status of embryos, treatment outcomes continue to depend on multiple clinical factors, and no fertility procedure can guarantee a successful pregnancy.
What Research Suggests About PGT-A
Research suggests that PGT-A may be beneficial in certain clinical situations, including advanced maternal age and a history of recurrent pregnancy loss. However, the decision to include PGT-A in an IVF treatment plan should be based on an individual's fertility health, medical history, and clinical recommendations.
Factors That Influence IVF Outcomes With PGT-A
Several factors continue to influence treatment outcomes, including:
- Female age
- Egg quality
- Sperm quality
- Uterine health
- Number of embryos available
- Laboratory standards
While PGT-A provides additional information about embryo chromosomal status, it is only one component of the overall fertility treatment process.
The "Euploid Embryo" Advantage
A euploid embryo has the expected number of chromosomes. Identifying euploid embryos through chromosomal screening during IVF may provide additional information that can support embryo selection decisions and treatment planning.
When PGT-A May Not Improve Outcomes
PGT-A may not be recommended in every IVF cycle. The decision to proceed with testing depends on several factors, including the couple's fertility health, medical history, treatment goals, and the fertility specialist's clinical assessment. For this reason, recommendations regarding PGT-A are made on an individual basis rather than through a standard approach for all patients.
Ethical Considerations and Emotional Aspects
In addition to clinical considerations, PGT-A may involve emotional and ethical discussions for some couples. Understanding these aspects can help patients feel better informed throughout the decision-making process.
Handling Embryos Deemed Aneuploid
When genetic testing identifies chromosomal abnormalities in embryos, couples may need to make important decisions regarding their treatment plan. Fertility specialists and genetic counsellors can help explain the findings, discuss available options, and provide guidance based on the couple's individual circumstances.
The Psychological Weight of Testing
The period between embryo testing and receiving results can be emotionally challenging for some patients. Uncertainty surrounding treatment outcomes may lead to feelings of anticipation, anxiety, or concern. Ongoing communication with the fertility team can help patients better understand the process and address any questions that arise during this stage of treatment.
Counseling Requirements Before Proceeding
Before undergoing PGT-A, fertility specialists may recommend counselling or detailed clinical discussions to ensure couples understand the purpose, benefits, limitations, and possible outcomes of testing. These conversations support informed decision-making and help align treatment choices with the couple's fertility goals and medical needs.
Conclusion
IVF with PGT-A in Mumbai may be considered for couples facing recurrent pregnancy loss, repeated implantation failure, advanced maternal age, or other clinical situations where additional information about embryo chromosomal status may be beneficial. As a form of preimplantation genetic testing, PGT-A can support informed treatment planning by providing insights that help fertility specialists make evidence-based embryo transfer decisions.
At Nova IVF Fertility, preimplantation genetic testing is supported by experienced fertility specialists, skilled embryologists, and advanced laboratory technology. Through personalised fertility care and comprehensive clinical support, the team aims to help couples navigate their fertility journey with confidence and clarity.
Related Fertility Blogs
